Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Menu

    Soquelitinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 185,288Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Corvus Pharma' Business Update & Q2 2025 Financial Results
    Corvus Pharma' Business Update & Q2 2025 Financial Results

    31 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/31/3125360/0/en/Corvus-Pharmaceuticals-to-Provide-Business-Update-and-Second-Quarter-2025-Financial-Results-on-August-7-2025.html

    GLOBENEWSWIRE
    31 Jul 2025
    Share Share
    Corvus Partner Angel Pharma get IND Approval for a Ph 1b/2 Trial
    Corvus Partner Angel Pharma get IND Approval for a Ph 1b/2 Trial

    25 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/25/3105021/0/en/Corvus-Pharmaceuticals-Announces-Partner-Angel-Pharmaceuticals-Received-IND-Approval-for-a-Phase-1b-2-Clinical-Trial-of-Soquelitinib-in-China-for-the-Treatment-of-Atopic-Dermatitis.html

    GLOBENEWSWIRE
    25 Jun 2025
    Share Share
    Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data at
    Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data at

    11 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/11/3097429/0/en/Corvus-Pharmaceuticals-Presents-Soquelitinib-Preclinical-Data-Highlighting-Potential-of-ITK-inhibition-to-Treat-Systemic-Sclerosis-at-EULAR-2025-Congress.html

    GLOBENEWSWIRE
    11 Jun 2025
    Share Share
    Corvus Shares Full Ph1 Data for Soquelitinib in Atopic Dermatitis
    Corvus Shares Full Ph1 Data for Soquelitinib in Atopic Dermatitis

    04 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/04/3093421/0/en/Corvus-Pharmaceuticals-Announces-Full-Data-from-Cohort-3-of-Placebo-Controlled-Phase-1-Clinical-Trial-of-Soquelitinib-for-Atopic-Dermatitis.html

    GLOBENEWSWIRE
    04 Jun 2025
    Share Share
    Corvus Pharmaceuticals Releases Data from Soquelitinib Trial
    Corvus Pharmaceuticals Releases Data from Soquelitinib Trial

    08 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/08/3077670/0/en/Corvus-Pharmaceuticals-Announces-Data-from-Cohorts-1-3-of-Placebo-Controlled-Phase-1-Clinical-Trial-of-Soquelitinib-for-Atopic-Dermatitis.html

    GLOBENEWSWIRE
    08 May 2025
    Share Share
    Corvus Pharmaceuticals to Present New Data on Soquelitinib Trial
    Corvus Pharmaceuticals to Present New Data on Soquelitinib Trial

    23 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/23/3066897/0/en/Corvus-Pharmaceuticals-to-Present-New-Interim-Data-from-Placebo-Controlled-Phase-1-Clinical-Trial-of-Soquelitinib-for-Atopic-Dermatitis-on-May-8-2025.html

    GLOBENEWSWIRE
    23 Apr 2025
    Share Share